Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1122155
PUBLISHER: Grand View Research | PRODUCT CODE: 1122155
Paracetamol IV Market Size, Share & Trends Analysis Report By Application (Surgical, Non-surgical), By Indication (Pyrexia, Pain), By End-use (Hospitals, Clinics), By Region (APAC, Europe), And Segment Forecasts, 2022 - 2030
PUBLISHED:
PAGES: 80 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Paracetamol IV Market Growth & Trends:
The global paracetamol IV market size is expected to reach USD 994.23 million by 2030, registering a CAGR of 3.97% from 2022 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic disorders that requires pain management is expected to facilitate the growth of the industry during the forecast period. The enhanced usage of acetaminophen to reduce the dependence on opioids for pain management is projected to accelerate the growth in demand for paracetamol IV. The IV paracetamol is a stable acetaminophen form and is intended for mild to moderate pain management. It is used over other NSAIDs to treat patients with a history of peptic ulcers and asthma, as it lacks interference with the function of platelets.
Rising cases of patients reporting postoperative pain are expected to propel the demand for drugs and products with fewer side effects. As per the article published in the International Journal of Surgery, in March 2022, 77% - 83% of patients in the U.S., 80% of patients in Thailand, 76% of patients in Sweden, and 29.5% of patients in Germany reported severe to moderate postoperative pain. The IV paracetamol is intended for usage in the treatment of acute postoperative pain and during the surgeries, such as orthopedic, dental, and gynecological. A rise in the number of surgeries performed and patients experiencing post-operative pain is expected to create a high product demand in the years to come. However, the availability of multiple generic products is expected to hinder the industry during the forecast period.
For instance, in December 2020, Sandoz International GmbH launched a generic acetaminophen injection in the U.S. The product will be available in 10 mg/mL concentration, in a 100 mL vial for the treatment of mild to moderate in conjunction with opioid analgesics for pediatric patients. Key players operating in the global industry are following various strategic initiatives for business expansion and to gain a competitive edge over others. For instance, in December 2021, Leucadia Pharmaceuticals launched and announced the availability of a generic acetaminophen injection, which is an FDA-approved generic that corresponds to the acetaminophen injection manufactured by Mallinckrodt Pharmaceuticals.
Paracetamol IV Market Report Highlights:
- Based on application, the pyrexia segment is estimated to register the fastest CAGR from 2022 to 2030
- The growth of the segment is attributed to the rapid action & effectiveness of paracetamol being administered intravenously
- The surgical application segment held the largest revenue share in 2021 due to the increased usage of paracetamol IV for the treatment of post-operative pain and rapid relief from fever
- North America dominated the global industry in 2021 owing to high product usage for reducing the dependence of the economy on opioids for the management of pain
- Companies are focusing on geographical expansion by adopting strategies, such as collaborations, partnerships, new product launches, and strategic initiatives to maintain a competitive position in the industry
Product Code: GVR-4-68039-965-3
Table of Contents
Chapter 1 Paracetamol IV Market: Methodology and Scope
- 1.1 Research Methodology
- 1.2 Research Assumptions
- 1.2.1 Estimates and forecast timeline
- 1.3 Information Procurement
- 1.3.1 Purchased database
- 1.3.2 GVR's internal database
- 1.3.3 Secondary sources
- 1.3.4 Primary research
- 1.3.5 Details of primary research
- 1.4 Information or Data Analysis
- 1.4.1 Data analysis models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity flow analysis
- 1.6.1.1 Approach 1: Commodity flow approach
- 1.6.2 Volume price analysis (model 2)
- 1.6.2.1 Approach 2: Volume price analysis
- 1.6.2.2 Revenue modeling
- 1.6.1 Commodity flow analysis
- 1.7 List of Secondary Sources
- 1.8 List of Primary Sources
Chapter 2 Paracetamol IV Market: Executive Summary
- 2.1 Paracetamol IV Market: Market Outlook
- 2.1.1 Market Summary
Chapter 3 Paracetamol IV Market: Industry Outlook
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.2 Penetration & Growth Prospect Mapping for Microbiome Therapeutics,2021
- 3.3 Market Dynamics
- 3.3.1 Market Driver Analysis
- 3.3.1.1 Rising cases of postoperative pain
- 3.3.1.2 Increasing prevalence of chronic disorders
- 3.3.1.3 Increasing use of intravenous paracetamol in combination with NSAIDs and narcotics
- 3.3.2 Market Restraint Analysis
- 3.3.2.1 Overdose of paracetamol IV
- 3.3.2.2 Availability of generic products
- 3.3.1 Market Driver Analysis
- 3.4 Paracetamol IV Market - Porter's Five Forces Analysis
- 3.4.1 Porter's Five Forces analysis
- 3.4.1.1 Competitive rivalry
- 3.4.1.2 Threat of new entrants
- 3.4.1.3 Threat of substitutes
- 3.4.1.4 Bargaining power of suppliers
- 3.4.1.5 Bargaining power of buyers
- 3.4.1 Porter's Five Forces analysis
- 3.5 Paracetamol IV Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
- 3.6 Paracetamol IV Market - Regulatory Framework
- 3.7 Paracetamol IV Market - User Perspective Analysis
Chapter 4 Paracetamol IV Market: Competitive Landscape
- 4.1 Company/Competition Categorization (Key Innovators, Market leaders, Emerging Players)
- 4.2 Strategy Framework
- 4.3 Market Participation Categorization
- 4.4 Recent Developments & Impact Analysis, by Key Market Participants
- 4.5 Company Position Analysis
- 4.6 List of Distributors
- 4.6.1 Key Customers
- 4.6.2 Public Companies
- 4.6.3 Private Companies
- 4.7 Major Deals and Strategic Alliances
- 4.7.1 Joint Ventures
- 4.7.2 Acquisitions
- 4.7.3 Licensing and Partnerships
- 4.7.4 Technological Collaborations
Chapter 5 Paracetamol IV Market: Indication Business Analysis
- 5.1 Definition and Scope
- 5.2 Indication Market Share Analysis, 2021 & 2030
- 5.3 Segment Dashboard
- 5.4 Global Paracetamol IV Market, By Indication, 2018 To 2030
- 5.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 5.5.1 Pain
- 5.5.1.1 Pain Market 2018 - 2030 (USD Million)
- 5.5.2 Pyrexia (Fever)
- 5.5.2.1 Pyrexia (Fever) Market, 2018 - 2030 (USD Million)
- 5.5.1 Pain
Chapter 6 Paracetamol IV Market: Application Business Analysis
- 6.1 Definition and Scope
- 6.2 Application Market Share Analysis, 2021 & 2030
- 6.3 Segment Dashboard
- 6.4 Global Paracetamol IV Market, By Application, 2018 To 2030
- 6.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 6.5.1 Surgical
- 6.5.1.1 Surgical Market 2018 - 2030 (USD Million)
- 6.5.2 Non-surgical
- 6.5.2.1 Non-surgical Market, 2018 - 2030 (USD Million)
- 6.5.1 Surgical
Chapter 7 Paracetamol IV Market: End-use Business Analysis
- 7.1 Definition and Scope
- 7.2 End-use Market Share Analysis, 2021 & 2030
- 7.3 Segment Dashboard
- 7.4 Global Paracetamol IV Market, By End-use, 2018 To 2030
- 7.5 Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 7.5.1 Hospitals
- 7.5.1.1 Hospitals Market 2018 - 2030 (USD Million)
- 7.5.2 Clinics
- 7.5.2.1 Clinics Market, 2018 - 2030 (USD Million)
- 7.5.3 Others
- 7.5.3.1 Others Market, 2018 - 2030 (USD Million)
- 7.5.1 Hospitals
Chapter 8 Paracetamol IV Market: Regional Business Analysis
- 8.1 Definition & Scope
- 8.2 Regional Market Share Analysis, 2021 & 2030
- 8.3 Regional Market Dashboard
- 8.4 Regional Market Snapshot
- 8.5 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- 8.5.1 North America
- 8.5.2 Europe
- 8.5.3 Asia Pacific
- 8.5.4 Latin America
- 8.5.5 MEA
- 8.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
- 8.7 North America
- 8.7.1 North America Market Estimates and Forecast, 2018 - 2030 (USD Million)
- 8.7.2 U.S.
- 8.7.2.1 U.S. Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.7.3 Canada
- 8.7.3.1 Canada Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.8 Europe
- 8.8.1 Europe Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.8.2 U.K.
- 8.8.2.1 U.K. Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.8.3 Germany
- 8.8.3.1 Germany Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.8.4 France
- 8.8.4.1 France Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.8.5 Italy
- 8.8.5.1 Italy Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.8.6 Spain
- 8.8.6.1 Spain Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.9 Asia Pacific
- 8.9.1 Asia Pacific Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.9.2 Japan
- 8.9.2.1 Japan Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.9.3 China
- 8.9.3.1 China Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.9.4 India
- 8.9.4.1 India Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.10.4 Australia
- 8.10.4.1 Australia Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.10.5 South Korea
- 8.10.5.1 South Korea Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.11 Latin America
- 8.11.1 Latin America Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.11.2 Brazil
- 8.11.2.1 Brazil Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.11.3 Mexico
- 8.11.3.1 Mexico Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.11.4 Argentina
- 8.11.4.1 Argentina Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.12 MEA
- 8.12.1 MEA Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.12.2 South Africa
- 8.12.2.1 South Africa Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.12.3 Saudi Arabia
- 8.12.3.1 Saudi Arabia Paracetamol IV Market, 2018 - 2030 (USD Million)
- 8.12.4 UAE
- 8.12.4.1 UAE Paracetamol IV Market, 2018 - 2030 (USD Million)
Chapter 9 Paracetamol IV Market: Company Profiling
- 9.1 Company Profiles
- 9.1.1. Mallinckrodt (Mallinckrodt Pharmaceuticals)
- 9.1.1.1 Company overview
- 9.1.1.2 Financial performance
- 9.1.1.3 Product benchmarking
- 9.1.1.4 Strategic initiatives
- 9.1.2. Cipla Inc.
- 9.1.2.1 Company overview
- 9.1.2.2 Financial performance
- 9.1.2.3 Product benchmarking
- 9.1.2.4 Strategic initiatives
- 9.1.3. Lupin
- 9.1.3.1 Company overview
- 9.1.3.2 Financial performance
- 9.1.3.3 Product benchmarking
- 9.1.3.4 Strategic initiatives
- 9.1.4. Dr. Reddy's Laboratories Ltd.
- 9.1.4.1 Company overview
- 9.1.4.2 Financial performance
- 9.1.4.3 Product benchmarking
- 9.1.4.4 Strategic initiatives
- 9.1.5. Aurobindo Pharma
- 9.1.5.1 Company overview
- 9.1.5.2 Financial performance
- 9.1.5.3 Product benchmarking
- 9.1.5.4 Strategic initiatives
- 9.1.6. Sun Pharmaceutical Industries Limited
- 9.1.6.1 Company overview
- 9.1.6.2 Financial performance
- 9.1.6.3 Product benchmarking
- 9.1.6.4 Strategic initiatives
- 9.1.7. Novartis AG
- 9.1.7.1 Company overview
- 9.1.7.2 Financial performance
- 9.1.7.3 Product benchmarking
- 9.1.7.4 Strategic initiatives
- 9.1.8. Pfizer Inc.
- 9.1.8.1 Company overview
- 9.1.8.2 Financial performance
- 9.1.8.3 Product benchmarking
- 9.1.8.4 Strategic initiatives
- 9.1.9. Abbott
- 9.1.9.1 Company overview
- 9.1.9.2 Financial performance
- 9.1.9.3 Product benchmarking
- 9.1.9.4 Strategic initiatives
- 9.1.10. Sanofi
- 9.1.10.1 Company overview
- 9.1.10.2 Financial performance
- 9.1.10.3 Product benchmarking
- 9.1.10.4 Strategic initiatives
- 9.1.11. Bristol-Myers Squibb Company
- 9.1.11.1 Company overview
- 9.1.11.2 Financial performance
- 9.1.11.3 Product benchmarking
- 9.1.11.4 Strategic initiatives
- 9.1.1. Mallinckrodt (Mallinckrodt Pharmaceuticals)
Product Code: GVR-4-68039-965-3
List of Tables
- Table 1 List of Secondary Sources
- Table 2 List of Abbreviations
- Table 3 Regulatory Framework
- Table 4 Global Paracetamol IV Market, By Region, 2018 - 2030 (USD Million)
- Table 5 Global Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 6 Global Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 7 Global Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 8 North America Paracetamol IV Market, By Country, 2018 - 2030 (USD Million)
- Table 9 North America Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 10 North America Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 11 North America Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 12 U.S. Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 13 U.S. Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 14 U.S. Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 15 Canada Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 16 Canada Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 17 Canada Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 18 Europe Paracetamol IV Market, By Country, 2018 - 2030 (USD Million)
- Table 19 Europe Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 20 Europe Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 21 Europe Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 22 U.K. Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 23 U.K. Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 24 U.K. Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 25 Germany Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 26 Germany Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 27 Germany America Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 28 France Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 29 France Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 30 France Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 31 Spain Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 32 Spain Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 33 Spain Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 34 Italy Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 35 Italy Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 36 Italy Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 37 Asia Pacific Paracetamol IV Market, By Country, 2018 - 2030 (USD Million)
- Table 38 Asia Pacific Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 39 Asia Pacific Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 40 Asia Pacific Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 41 China Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 42 China Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 43 China Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 44 Japan Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 45 Japan Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 46 Japan Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 47 India Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 48 India Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 49 India Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 50 South Korea Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 51 South Korea Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 52 South Korea Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 53 Australia Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 54 Australia Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 55 Australia Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 56 Latin America Paracetamol IV Market, By Country, 2018 - 2030 (USD Million)
- Table 57 Latin America Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 58 Latin America Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 59 Latin America Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 60 Brazil Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 61 Brazil Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 62 Brazil Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 63 Mexico Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 64 Mexico Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 65 Mexico Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 66 Argentina Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 67 Argentina Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 68 Argentina Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 69 MEA Paracetamol IV Market, By Country, 2018 - 2030 (USD Million)
- Table 70 MEA Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 71 MEA Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 72 MEA Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 73 South Africa Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 74 South Africa Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 75 South Africa Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 76 UAE Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 77 UAE Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 78 UAE Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
- Table 79 Saudi Arabia Paracetamol IV Market, By Indication, 2018 - 2030 (USD Million)
- Table 80 Saudi Arabia Paracetamol IV Market, By Application, 2018 - 2030 (USD Million)
- Table 81 Saudi Arabia Paracetamol IV Market, By End-use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market Research Process
- Fig. 2 Information Procurement
- Fig. 3 Primary Research Pattern
- Fig. 4 Market Research Approaches
- Fig. 5 Value Chain-Based Sizing & Forecasting
- Fig. 6 Market Formulation & Validation
- Fig. 7 Paracetamol IV Market Segmentation
- Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
- Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
- Fig. 10 Penetration & Growth Prospect Mapping
- Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- Fig. 12 Porter's Five Forces Analysis
- Fig. 13 Market Penetration & Growth Prospect Mapping
- Fig. 14 Paracetamol IV Market: Indication Movement Analysis
- Fig. 15 Pain Market, 2018 - 2030 (USD Million)
- Fig. 16 Pyrexia(Fever) Market, 2018 - 2030 (USD Million)
- Fig. 17 Paracetamol IV Market: Application Movement Analysis
- Fig. 18 Surgical Market, 2018 - 2030 (USD Million)
- Fig. 19 Non-surgical Market, 2018 - 2030 (USD Million)
- Fig. 20 Paracetamol IV Market: End-use Movement Analysis
- Fig. 21 Hospitals Market, 2018 - 2030 (USD Million)
- Fig. 22 Clinics Market, 2018 - 2030 (USD Million)
- Fig. 23 Others Market, 2018 - 2030 (USD Million)
- Fig. 24 Regional Marketplace: Key Takeaways
- Fig. 25 Regional Outlook, 2018 & 2030
- Fig. 26 Regional Market Dashboard
- Fig. 27 Regional Market Place: Key Takeaways
- Fig. 28 North America, SWOT Analysis
- Fig. 29 Europe, SWOT Analysis
- Fig. 30 Asia Pacific, SWOT Analysis
- Fig. 31 Latin America, SWOT Analysis
- Fig. 32 MEA, SWOT Analysis
- Fig. 33 North America
- Fig. 34 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
- Fig. 35 U.S.
- Fig. 36 U.S. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 37 Canada
- Fig. 38 Canada Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 39 Europe
- Fig. 40 Europe Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 41 U.K
- Fig. 42 U.K. Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 43 Germany
- Fig. 44 Germany Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 45 France
- Fig. 46 France Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 47 Italy
- Fig. 48 Italy Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 49 Spain
- Fig. 50 Spain Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 51 Asia Pacific
- Fig. 52 Asia-Pacific Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 53 Japan
- Fig. 54 Japan Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 55 China
- Fig. 56 China Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 57 India
- Fig. 58 India Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 59 Australia
- Fig. 60 Australia Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 61 South Korea
- Fig. 62 South Korea Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 63 Latin America
- Fig. 64 Latin America Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 65 Brazil
- Fig. 66 Brazil Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 67 Mexico
- Fig. 68 Mexico Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 69 Argentina
- Fig. 70 Argentina Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 71 MEA
- Fig. 72 MEA Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 73 South Africa
- Fig. 74 South Africa Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 75 Saudi Arabia
- Fig. 76 Saudi Arabia Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 77 UAE
- Fig. 78 UAE Market Estimates and Forecast, 2018 - 2030 (USD Million)
- Fig. 79 Strategy Mapping
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.